Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter N. Kellogg currently holds 5,228 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter N. Kellogg has been a net seller of ALNY stock. They have purchased $502.4K and sold $1.8M worth of shares.
Peter N. Kellogg's most recent insider trade was on May 16, 2024, when they sold 5,228 shares at $0.00 per share.
Peter N. Kellogg serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 52 insider transactions totaling $2.3M over their tenure at the company.
Peter N. Kellogg holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Peter N. Kellogg has shown a selling trading pattern, with $502.4K in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter N. Kellogg was on Aug 1, 2017, when they sold $4.2M worth of CELG shares. This transaction involved 31,110 shares at $135.18 per share.
Peter N. Kellogg currently owns 5,228 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter N. Kellogg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter N. Kellogg has 52 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Peter N. Kellogg and 40,000+ other insiders.